 |
|
|
| |
A novel farnesoid X receptor agonist: EDP-305, reduces fibrosis progression in animal models of fibrosis
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam, Netherlands
Derek J. Erstad1, Christian T. Farrar2, Ricard Masia3, Diego Dos Santos Ferreira2, Lan Wei1, Ji-Kyung Choi2, Sarani Ghoshal1, Nicholas Rotile2, Yang Li4, Mary Chau4, Kenneth K. Tanabe1, Yat Sun Or4, Peter Caravan2, Li-Juan Jiang4, Bryan C. Fuchs* 1
1Surgery, Massachusetts General Hospital, Boston, 2Martinos Center, Massachusetts General Hospital, Charlestown, 3Pathology, Massachusetts General Hospital, Boston, 4Enanta Pharmaceuticals, Watertown, United States
|
| |
|
|
|
|
|
